Pulse

Based in Delhi, India, Pulse is a digital health solutions provider focused on enhancing user well-being through innovative health management tools. Pulse provides a digital health platform that allows users to monitor their health metrics in real-time. Founded by Andres K. , Peter Lauenstein-Denjongpa, and Kyosuke Togami, the company has secured funding from SAIF Partners, raising a total of USD 0.

5 mn. The firm is headquartered in Delhi, India, and its most recent funding round occurred on November 29, 2016. The core offerings of Pulse, identified as MyPulse, center around an innovative suite of digital health solutions designed to enhance user well-being and facilitate health management. Their flagship product, a comprehensive health monitoring platform, allows users to track various health metrics in real-time, providing insights that empower individuals to make informed decisions about their health.

The platform is adaptable for both personal users and healthcare providers, aiming to bridge the gap between patient data and clinical decision-making. MyPulse serves a diverse client base, including healthcare institutions, fitness enthusiasts, and corporate wellness programs, primarily across North America and Europe. The company's solutions specifically target issues related to chronic disease management, wellness optimization, and telehealth integration, with the aim of improving overall health outcomes. The revenue model of MyPulse is structured around a combination of subscription services and partnerships with healthcare organizations.

Clients can engage with the platform through various pricing tiers, with options tailored to personal users, corporate clients, and healthcare professionals. For instance, individual users may subscribe to a monthly plan that grants access to the full suite of health monitoring tools, while corporate customers may enter into longer-term agreements that include additional features such as employee wellness reports and analytics. Partnerships with healthcare providers often involve revenue-sharing agreements based on the utilization of the platform within clinical settings. The company’s transaction structure effectively positions it to capitalize on recurring revenue streams while providing value to both end users and institutional clients.

In the near future, Pulse plans to enhance its product offerings with new features designed to improve user engagement and health data analysis. The company is also targeting expansion into markets in Asia and Europe by 2024, seeking to establish partnerships with local health organizations. The recent funding of USD 0. 5 mn raised in November 2016 will be utilized to support these initiatives, focusing on product development and market entry strategies.